InterCure Shares Soar On FY22 Record Revenue Of $108.3M

InterCure Ltd. INCR INCR INCR (dba Canndoc) fiscal year 2022 revenue was NIS 388.7 million ($108.3 million), an increase of 77% compared to NIS 219.7 million in 2021.

Full Year 2022 Financial Highlights for Cannabis Sector

  • Gross profit of NIS 37 million, gross margin of 35% dropped from 44% QoQ.

  • Adjusted EBITDA of NIS 19 million, representing 18% of revenues.

  • Net income (consolidated) of CA$16 million.

  • Cash (consolidated) at year end of CA$95 million.

Q4 Financial Highlights for Cannabis Sector

  • Record revenue of CA$41 million 33% growth YoY and 5% QoQ growth.

  • Gross profit of CA$14 million, gross margin of 35% dropped from 44% QoQ.

  • Adjusted EBITDA of NIS 19 million, representing 18% of revenues.

“We are pleased to report another record-breaking quarter and fiscal year for InterCure, solidifying our leading position," stated InterCure CEO Alexander Rabinovich, adding “As our target markets are evolving, we remain focused on execution with financial discipline while navigating through regulatory barriers and market challenges. During 2022, we have successfully ramped up our upstream global supply chain and scaled our downstream distribution operations to meet the solid demand for our high-quality branded products. While favorable regulatory cannabis reforms are on the horizon, we expect our growth journey to continue as we remain focused and committed to expand our leading platform, building shareholder value and improving quality of life for patient communities across the world.”

Price Action

InterCure shares were trading 17.65% higher during Monday’s pre-market session.

Benzinga's Cannabis Capital Conference Is Back

The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition. This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out. Secure your tickets now. Prices will surge very soon.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsAlexander RabinovichpremiumWhy is it moving?
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.